The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all-trans retinoic acid in patients with acute myeloid leukemia (Q34472275)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all-trans retinoic acid in patients with acute myeloid leukemia
scientific article

    Statements

    The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all-trans retinoic acid in patients with acute myeloid leukemia (English)
    Andrea Kuendgen
    Mathias Schmid
    Richard Schlenk
    Sabine Knipp
    Barbara Hildebrandt
    Christian Steidl
    Rainer Haas
    1 January 2006

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit